Guidelines for Infection Prophylaxis, Monitoring and Therapy in Cord Blood Transplantation

Keyphrases

• Infection Surveillance 100%
• Cord Blood Transplantation 100%
• Infection Therapy 100%
• Infection Prophylaxis 100%
• Letermovir 50%
• Graft-versus-host Disease (GvHD) 50%
• Viral 50%
• Opportunistic Infections 50%
• Transplant Recipients 50%
• Data Practices 50%
• Adult Patients 50%
• Infectious Diseases 50%
• High Risk 50%
• Cord Blood 50%
• Pneumocystis 50%
• Evidence-based Recommendations 50%
• Toxoplasmosis 50%
• Infectious Complications 50%
• Paucity 50%
• Practice Recommendations 50%
• Stem Cell Source 50%
• Antimicrobial Prophylaxis 50%
• Virus Therapy 50%
• CMV Reactivation 50%
• Delayed Engraftment 50%

Medicine and Dentistry

• Infection 100%
• Cord Blood 100%
• Infection Prevention 100%
• Cord Blood Stem Cell Transplantation 100%
• Opportunistic Infection 50%
• Engraftment 50%
• Antiinfective Agent 50%
• Acute Graft Versus Host Disease 50%
• Stem Cell 50%
• Toxoplasmosis 50%
• Infectious Complication 50%
• Letermovir 50%
• Virotherapy 50%

Immunology and Microbiology

• Cord Blood Stem Cell Transplantation 100%
• Infection 100%
• Infectious Disease 33%
• Engraftment 33%
• Stem Cell 33%
• Acute Graft Versus Host Disease 33%
• Pneumocystis 33%
• Toxoplasmosis 33%
• Virotherapy 33%
• Opportunistic Infection 33%